A Biete
Overview
Explore the profile of A Biete including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
390
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Gomez G, Ascaso C, Herreros A, Fornes B, Mases J, et al.
Clin Transl Oncol
. 2021 Dec;
24(5):875-881.
PMID: 34854030
Purpose: To evaluate the preliminary results of the use of 68 Gy EQD2 as a dose limit to the lowest dose in the most exposed 2 cm of the vagina...
2.
Oses G, Cases C, Valduvieco I, Farrus B, Alonso I, Caparros X, et al.
Clin Transl Oncol
. 2021 Feb;
23(8):1593-1600.
PMID: 33534078
Purpose: The administration of a dose boost to the tumor bed after breast-conserving surgery has proven to reduce local recurrence. Intra-operative electron radiotherapy (IOERT) offers an alternative method to deliver...
3.
Holub K, Vargas A, Biete A
Clin Transl Oncol
. 2020 Apr;
22(11):2040-2048.
PMID: 32285291
Background: Although the chemotherapy-induced depletion of circulating white blood cells (WBC) is well recognized, the impact of exclusive radiotherapy (RT) on the different subpopulations of WBC remains unexplored. This may...
4.
Zhang Y, Ascaso C, Herreros A, Sanchez J, Del Pino M, Torne A, et al.
Clin Transl Oncol
. 2019 Dec;
22(8):1295-1302.
PMID: 31865604
Purpose: To determine whether brachytherapy with a single hypofractionated dose of 7 Gy provides the similar vaginal-cuff relapses and safety profile in terms of complications compared to schedules of 2...
5.
Cambra M, Moreno F, Sanz X, Anglada L, Molla M, Reyes V, et al.
Clin Transl Oncol
. 2019 Jul;
22(5):670-680.
PMID: 31264148
Purpose: To evaluate the effect of boost radiotherapy on ipsilateral breast tumor recurrence (IBTR) for ductal carcinoma in situ (DCIS) after breast-conserving surgery and whole breast radiotherapy (WBRT) with or...
6.
Holub K, Biete A
Clin Transl Oncol
. 2018 Nov;
21(7):836-844.
PMID: 30470994
Background: Inflammatory biomarkers have recently attracted attention as valuable prognosticators and predictors of survival outcomes in many cancers. We describe a new pre-treatment biomarker, expressed as the eosinophil-lymphocytes ratio (ELR)...
7.
Biete A, Holub K
Clin Transl Oncol
. 2017 Jun;
19(12):1518-1523.
PMID: 28577151
Purpose: To evaluate the level of anaemia monitoring and to determine the prevalence of anaemia in patients with endometrial carcinoma (EC) undergoing postoperative pelvic radiotherapy (RT). Methods: We evaluated 233...
8.
Rios I, Rovirosa A, Ascaso C, Valduvieco I, Herreros A, Castilla L, et al.
Clin Transl Oncol
. 2015 Dec;
18(9):925-30.
PMID: 26661111
Purpose: To analyze the vaginal-cuff local control (VCC) and toxicity in postoperative endometrial carcinoma patients (EC) underwent high-dose-rate brachytherapy (HDR-BT) administered daily. Materials And Methods: 154 consecutive patients received postoperative...
9.
Valduvieco I, Rovirosa A, Herreros A, Romera I, Rios I, Ascaso C, et al.
Clin Transl Oncol
. 2012 Dec;
15(8):602-7.
PMID: 23263910
Background: High-dose-rate brachytherapy (HDR-BT) is an accepted part of treatment for endometrial carcinoma and is usually performed in 1-2 fractions per week using different total doses and doses per fraction....
10.
Arenas M, Sabater S, Hernandez V, Rovirosa A, Lara P, Biete A, et al.
Strahlenther Onkol
. 2012 Aug;
188(11):975-81.
PMID: 22907572
Low-dose radiotherapy (LD-RT) has been used for several benign diseases, including arthrodegenerative and inflammatory pathologies. Despite its effectiveness in clinical practice, little is known about the mechanisms through which LD-RT...